Immunotherapy should be considered in conditions where protection from allergens is not possible, reactions are life-threatening and the response to drug treatment is low. Allergen SIT is currently the only treatment method that can change the natural course of allergic diseases and has long-term effects.
Immunotherapy can be very effective in controlling allergy symptoms. Subcutaneous specific immunotherapy is the administration of increasing doses of the specific allergen under the skin until the maximum tolerated dose is reached. Injection applications start with once or twice a week; Once the maintenance dose is reached, the treatment is administered once a month and continued for 3-5 years. Vaccines have also been developed in sublingual tablet form. Pollen mixture tablets are licensed in our country. In Europe and America, in addition to pollen mixtures, forms for house dust mites are also used.
Unlike drug treatment, the effect of specific immunotherapy continues after the end of treatment.
With this method, grass pollens, house dust mites are also used. Vaccination can be done against dust mites, mold fungi, various tree pollens, animal epithelium (cat dander).
Specific immunotherapy is an effective method in the treatment of allergic rhinitis (flu), bee allergy and asthma. In recent years, it has also been approved for use in atopic dermatitis. Immunotherapy reduces asthma symptoms and the use of asthma medications and improves bronchial hyperactivity.
Immunotherapy should be applied by a specialist physician and the patient should be observed for at least 30 minutes after the application. Specific immunotherapy is effective and useful in appropriate patients, including children.
Read: 0
